30% Florfenicol injection
Ihe omume ọgwụ
Florfenicol bụ ọgwụ nje na-egbu egbu nke mmanya amide na onye na-ahụ maka bacteriostatic.Ọ na-eme site na ijikọ na mpaghara 50S nke ribosome iji gbochie njikọ nke protein nje.Ọ nwere ọrụ antibacterial siri ike megide ụdị nje bacteria gram-positive na gram-adịghị mma.Pasteurella hemolyticus, Pasteurella multocida na Actinobacillus pleuropneumoniae na-enwe mmetụta nke ukwuu na florfenicol.Ọrụ antibacterial nke florfenicol megide ọtụtụ microorganisms in vitro yiri ma ọ bụ sie ike karịa nke thiamphenicol.Ụfọdụ nje bacteria na-eguzogide ọgwụ amide n'ihi acetylation, dị ka Escherichia coli na Klebsiella pneumoniae, nwere ike ka na-eguzogide fluorobenzene.Nico nwere mmetụta.A na-ejikarị ya eme ihe maka ọrịa nje nke ezì, ọkụkọ na azụ nke nje bacteria na-emetụ n'ahụ kpatara, dị ka ọrịa iku ume nke ehi na ezì kpatara Pasteurella hemolyticus, Pasteurella multocida na Actinobacillus pleuropneumoniae.Salmonella kpatara ahụ ọkụ typhoid na ahụ ọkụ paratyphoid, ọgbụgbọ ọkụkọ, pullorum ọkụkọ, colibacillosis, wdg;sepsis nke nje bacteria kpatara azụ pasteurella, vibrio, Staphylococcus aureus, hydrophila, enteritidis, wdg. Enteritis, ọrịa anụ ahụ na-acha uhie uhie, wdg.
Pharmacokinetics
Florfenicol na-etinye uche ngwa ngwa site na nchịkwa ọnụ, yana enwere ike ịbanye n'ime ọgwụgwọ ahụ n'ime ọbara mgbe ihe dị ka elekere 1 gachara, enwere ike iru ogo ọbara kacha elu n'ime awa 1 ruo 3.Bioavailability karịrị 80%.A na-ekesa Florfenicol n'ọtụtụ ebe n'ime anụmanụ ma nwee ike ịbanye n'ime mgbochi ụbụrụ ọbara.A na-ebupụ ya na mmamịrị n'ụdị mbụ ya, a na-ewepụkwa obere ego na nsị.
Omume na ojiji
Ọgwụ nje Amidol.Maka ọrịa Pasteurella na E. coli.
Usoro onunu ogwu na nchịkwa
Ngwunye intramuscular: otu dose, 0.067 ml maka ọkụkọ na 0.05 ~ 0.067 ml maka ezì kwa 1 n'arọ arọ.Kwa awa 48 maka 2 doses.Azụ 0.0017 ~ 0.0034ml, qd.
Mmeghachi omume ọjọọ
1.30% ogwu ogwu nke Florfenicolnwere ụfọdụ mmetụta immunosuppressive mgbe ejiri ya na doses dị elu karịa ọgwụ akwadoro.
2. O nwere embryotoxicity na ekwesịrị iji nlezianya mee ihe na anụ ụlọ n'oge ime na lactation.
Mkpachapụ anya:
1. Ọ bụ contraindicated na ịtọ ọkụkọ n'oge ịtọ oge.
2. A na-egbochi ya n'oge ịgba ọgwụ mgbochi ọrịa ma ọ bụ n'ime anụmanụ ndị nwere nnukwu ọrụ mgbochi ọrịa.
3. Mbelata dose kwesịrị ekwesị ma ọ bụ ịgbatị ogologo oge nke dosing ka achọrọ n'anụmanụ emetụtara nwere ụkọ akụrụ.
Oge mwepụ
Ezi ụbọchị 14, ọkụkọ ụbọchị 28.
Hebei Veyong Pharmaceutical Co., Ltd, e guzobere na 2002, emi odude ke Shijiazhuang City, Hebei Province, China, na-esote Isi Obodo Beijing.Ọ bụ nnukwu ụlọ ọrụ ọgwụ anụmanụ enwetara ikike nke GMP, yana R&D, mmepụta na ire nke API ọgwụgwọ anụmanụ, nkwadebe, nri agbakwunyere na mgbakwunye nri.Dị ka Provincial Technical Center, Veyong eguzobela usoro R&D ọhụrụ maka ọgwụ anụmanụ ọhụrụ, ma bụrụ ụlọ ọrụ mmepụta ihe ọhụrụ na teknụzụ nke mba ama ama, enwere ndị ọkachamara teknụzụ 65.Veyong nwere abụọ mmepụta bases: Shijiazhuang na Ordos, nke Shijiazhuang isi na-ekpuchi ebe 78,706 m2, na 13 API ngwaahịa gụnyere Ivermectin, Eprinomectin, Tiamulin Fumarate, Oxytetracycline hydrochloride ects, na 11 nkwadebe mmepụta akara gụnyere injection, oral ngwọta, ntụ ntụ ngwọta. , premix, bolus, pesticides na disinfectant, wdg.Veyong na-enye API, ihe karịrị 100 nkwado akara aha, yana ọrụ OEM & ODM.
Veyong na-etinye aka na njikwa nke sistemụ EHS (Environment, Health & Safety), ma nweta asambodo ISO14001 na OHSAS18001.Edepụtara Veyong n'ime ụlọ ọrụ mmepụta ihe na-emepụta atụmatụ dị na Hebei Province ma nwee ike hụ na ngwaahịa na-aga n'ihu.
Veyong guzobere usoro njikwa mma zuru oke, nweta asambodo ISO9001, asambodo China GMP, asambodo Australia APVMA GMP, asambodo Ethiopia GMP, asambodo Ivermectin CEP, wee gafere nyocha US FDA.Veyong nwere ọkachamara otu ndebanye aha, ahịa na ọrụ teknụzụ, ụlọ ọrụ anyị enwetala ntụkwasị obi na nkwado site n'aka ọtụtụ ndị ahịa site n'ịdị mma ngwaahịa dị mma, ọrụ tupu ire ere na mgbe ire ere, ọrụ siri ike na sayensị.Veyong emewo ogologo okwu imekọ ihe ọnụ na ọtụtụ mba ụwa maara na-emepụta ọgwụ ụlọ ọrụ na ngwaahịa exported na Europe, South America, Middle East, Africa, Asia, wdg karịa 60 mba na mpaghara.